Inside Reproductive Health Podcast

3 fertility specialists have built massive digital brands with millions of collective followers.
In this episode, Dr. Aimee Eyvazzadeh (The Egg Whisperer), Dr. Roohi Jeelani (CEO of Onto Health), and Dr. Lucky Sekhon (Partner at RMA New York) discuss how they embody the same raw talent but leverage their public profiles for very different aims.
They dive into:
How fertility physicians build celebrity-level digital brands

The strategies behind maintaining a successful self-pay practice

Pursuing creative endeavors outside the clinic (like authoring a book)

Scaling a clinic group and building a tech-enabled OB/GYN referral network

Why Dr. Aimee added Juniper Genomics to her PGT roster

Game-changing innovation doesn’t happen by accident. 
It happens when the best minds in fertility are constantly testing, improving, and challenging what’s possible. 
We dive into this notion with Dr. Rita Vassena, Medical Director of Fertility at CooperSurgical. She spends her time visiting high-performing IVF labs around the world, identifying the technologies, processes, and ideas that are shaping the future of reproductive medicine. 
We discuss: 
What it will take to double IVF cycle output in the next five years 

How vitrification can be performed up to 90% faster 

CooperSurgical’s rapid blastocyst warming technology 

Emerging concepts that could reshape fertility treatment 

What leading lab directors are doing to maximize workflows and IVF supplies 

The next generation of fertility care is already taking shape - get a glimpse of what may be coming next.

Is PGT as we know it coming to an end?
Drs. Arlene Morales, Holly Mehr & Drew Tortoriello discuss what they see as the next evolution of PGT and why whole genome sequencing could reshape the future of embryo testing.
They dive into:
Why all PGT could include whole genome sequencing within five years

Concerns about PGT-P and direct-to-consumer marketing

What they want to hear from ASRM and other professional societies about genomics

What should be included in a large randomized controlled trial on PGT

Why they are cautiously optimistic about Juniper Genomics (And what makes PGT-G different)

Third-party IVF is getting bigger, but are clinics actually getting better at it?
Or are some efforts to streamline the process creating new risks for patients?
Dr. Allison Bloom of Main Line Fertility and Dr. Daniel Shapiro of Reproductive Biology Associates (RBA) discuss what separates a clinic that offers third-party reproduction from one that truly excels at it.
We dive into:
The push to streamline third-party IVF (and where corners may be getting cut)

The technology stack donor & surrogacy programs need

The gaps in today’s EMRs and what needs to change

Emerging trends around known donors

New thinking on anonymous vs. de-identified donation

One thing each physician believes clinics should start (or stop) doing to become a third-party IVF powerhouse

As third-party reproduction becomes more common, the operational, ethical, and technological challenges become harder to ignore.

More than half of IVF patients never complete treatment. 

Stress, finances, and relationship strain may play a role, but are fertility workflows optimized for cycles completed over families built also to blame?

In this episode, leaders from Inception Fertility share how they’re using technology, workflow design, and operational strategy to improve the patient journey from first inquiry through graduation.
What Inception uncovered by integrating their EMR with Salesforce

Insights into no-shows and cancellations from patient data analysis

Workflow improvements being implemented across staff and physicians

How to evaluate which solutions can scale network-wide

The build vs. buy debate around automation & more

How much friction still exists in your patient journey, and where could better systems make the biggest difference?